Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_assertion type Assertion NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_head.
- NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_assertion description "[Pathologically, high circulating levels of FGF23 result in hypophosphatemia, decreased production of 1,25(OH)(2)D, elevated parathyroid hormone and rickets/osteomalacia in patients with functioning kidneys, whereas low levels are associated with tumoral calcinosis, hyperphosphatemia and elevated 1,25(OH)(2)D. In addition, patients with chronic kidney disease (CKD) exhibit marked elevations of circulating FGF23.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_provenance.
- NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_assertion evidence source_evidence_literature NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_provenance.
- NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_assertion SIO_000772 17635819 NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_provenance.
- NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_assertion wasDerivedFrom befree-20150227 NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_provenance.
- NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_assertion wasGeneratedBy ECO_0000203 NP789438.RAnOyW7pCSac5OlY1EBLROFMhQbyVh1F4Sx3HkOEmeP1Y130_provenance.